SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-18-015496
Filing Date
2018-11-13
Accepted
2018-11-13 16:08:08
Documents
2
Period of Report
2018-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k111318_immucellcorp.htm 8-K 22897
2 PRESS RELEASE OF IMMUCELL CORPORATION DATED NOVEMBER 13, 2018. f8k111318ex99-1_immucellcorp.htm EX-99.1 63130
  Complete submission text file 0001213900-18-015496.txt   87117
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 181177995
SIC: 2835 In Vitro & In Vivo Diagnostic Substances